NewSquare Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16
Closed -$4 470
2024
Q1
$4 Hold
16
﹤0.01% 437
2023
Q4
$5 Hold
16
﹤0.01% 490
2023
Q3
$4 Sell
16
-110
-87% -$40 ﹤0.01% 593
2023
Q2
$64 Hold
126
﹤0.01% 813
2023
Q1
$83 Buy
126
+32
+34% +$22 ﹤0.01% 834
2022
Q4
$33 Buy
+94
New +$38 ﹤0.01% 804

Other funds holding ASXC

NewSquare Capital's ASXC Position: Q2 2024 in Review

NewSquare Capital sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 16 shares — an estimated $4 sold.

NewSquare Capital first reported a position in ASXC in Q4 2022 and held it in 6 quarters. The position peaked at $83 in Q1 2023. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

  • NewSquare Capital reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
  • NewSquare Capital sold 16 Asensus Surgical, Inc. shares in Q2 2024, an estimated $4.
  • NewSquare Capital first reported a position in Asensus Surgical, Inc. in Q4 2022 and held it in 6 quarters.
  • NewSquare Capital's Asensus Surgical, Inc. position peaked at $83 in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on NewSquare Capital's 13F filing for Q2 2024, filed 23 Jul 2024.